Longitudinal analysis of novel Alzheimer's disease proteomic cerebrospinal fluid biomarkers during intravenous immunoglobulin therapy. (Q55332383)

2 July 2018

title

Longitudinal analysis of novel Alzheimer's disease proteomic cerebrospinal fluid biomarkers during intravenous immunoglobulin therapy. (English)

1 reference

2 July 2018

0 references

0 references

1 reference

4

Kelvin H Lee

1 reference

2 July 2018

author name string

Gilda Shayan

series ordinal

1

1 reference

2 July 2018

Basia Adamiak

series ordinal

2

1 reference

2 July 2018

Norman R Relkin

series ordinal

3

1 reference

2 July 2018

publication date

1 July 2012

1 reference

2 July 2018

published in

Electrophoresis

1 reference

2 July 2018

volume

33

1 reference

2 July 2018

issue

13

1 reference

2 July 2018

page(s)

1975-1979

1 reference

2 July 2018

2009 Alzheimer's disease facts and figures

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

Proteomics: theoretical and experimental considerations.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5827947

12 August 2018

Identifiers

DOI

10.1002/ELPS.201100660

1 reference

2 July 2018

PMCID

5827947

1 reference

2 July 2018

PubMed ID

22806462

1 reference

2 July 2018